

( (S (NP-SBJ-1 (NP Wang Laboratories Inc.)
	       ,
	       (NP-LOC (NP Lowell)
		       ,
		       (NP Mass.)))
     ,
     (S-ADV (NP-SBJ *-1)
	    (VP beset
		(NP *)
		(PP by
		    (NP-LGS (NP declining demand)
			    (PP for
				(NP its computers))))))
     ,
     (VP reported
         (NP (NP a
		 (ADJP (QP $ 62.1 million) *U*)
		 ,
		 38-cents-a-share
		 loss)
	     (PP-LOC in
		     (NP (NP its first quarter)
			 (VP ended
			     (NP-TMP Sept. 30))))))
     .))
( (S (NP-SBJ Revenue)
     (VP fell
         (NP-EXT 12.7 %)
         (PP-DIR to
		 (NP (QP $ 596.8 million) *U*))
         (PP-DIR from
		 (NP (QP $ 684 million) *U*))
	 ,
	 (SBAR-ADV although
		   (S (NP-SBJ-1 (NP some)
				(PP of
				    (NP the decline)))
		      (VP was
			  (VP caused
			      (NP *-1)
			      (PP by
				  (NP-LGS discontinued operations)))))))
     .))
( (S (NP-SBJ Wang)
     (VP had
         (ADVP-TMP previously)
         (VP forecast
             (NP a loss)))
     .))
( (S (NP-SBJ The company)
     (VP reiterated
         (SBAR that
               (S (NP-SBJ it)
                  (VP expects
                      (NP (NP another loss)
			  (PP (PP-TMP in
				      (NP the second quarter))
			      and
			      (PP for
				  (NP the full year))))
		      ,
		      (SBAR-ADV although
				(S (NP-SBJ it)
				   (VP expects
				       (NP a profitable fourth quarter))))))))
     .))
( (S (ADVP-TMP (NP A year)
	       ago)
     ,
     (NP-SBJ Wang)
     (VP had
         (NP (NP earnings)
	     (PP of
		 (NP (NP (QP $ 13.1 million) *U*)
		     ,
		     or
		     (NP (NP eight cents)
			 (NP-ADV a share))
		     ,)))
	 (PP-TMP in
		 (NP its first quarter))
	 ,
	 (PP including
	     (NP (NP a
		     (ADJP (QP $ 3.1 million) *U*)
		     loss) 
		 (PP from
		     (NP discontinued operations)))))
     .))
( (S (NP-SBJ The latest period loss)
     (VP included
         (NP (NP a
		 (ADJP $ 12.9 *U*)
		 pretax charge) 
	     (PP for
                 (NP severance payments))))
     .))
